We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$82.3B
AUM Growth
+$3.23B
(+4.1%)
Cap. Flow
-$7.73B
Cap. Flow
% of AUM
-9.4%
Top 10 Holdings %
Top 10 Hldgs %
24.03%
Holding
2,474
New
201
Increased
562
Reduced
953
Closed
424
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$983M |
| 2 |
Exelon
EXC
|
+$595M |
| 3 |
Broadcom
AVGO
|
+$486M |
| 4 |
CRH
CRH
|
+$387M |
| 5 |
Marvell Technology
MRVL
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$795M |
| 2 |
Norfolk Southern
NSC
|
+$559M |
| 3 |
PPL
PPL Corp
PPL
|
+$355M |
| 4 |
Union Pacific
UNP
|
+$328M |
| 5 |
Cisco
CSCO
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.45% |
| 2 | Financials | 14.25% |
| 3 | Healthcare | 13.09% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Sutro Biopharma
STRO
$425M
| $92K | ﹤0.01% |
+1,639
| New | +$72.4K |
|
|
LGTY
1402
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $92K | ﹤0.01% |
+8,049
| New | +$90.6K |
|
1403
APi Group
APG
$18.1B
| $91K | ﹤0.01% |
3,512
-202
| -5% | -$4.7K |
|
1404
InterDigital
IDCC
$8.85B
| $91K | ﹤0.01% |
855
-1,441
| -63% | -$152K |
|
1405
TG Therapeutics
TGTX
$7.64B
| $91K | ﹤0.01% |
+6,073
| New | +$96.7K |
|
1406
Warner Bros
WBD
$66.9B
| $91K | ﹤0.01% |
10,558
+3,412
| +48% | +$32.9K |
|
|
PSTX
1407
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $91K | ﹤0.01% |
28,679
+21,138
| +280% | +$70.5K |
|
1408
AeroVironment
AVAV
$9.3B
| $90K | ﹤0.01% |
593
-181
| -23% | -$24.2K |
|
1409
Carnival Corporation Ltd
CCL
$39.7B
| $90K | ﹤0.01% |
+5,510
| New | +$89.6K |
|
1410
Denali Therapeutics
DNLI
$3.88B
| $90K | ﹤0.01% |
4,410
| – | – |
|
1411
Novanta
NOVT
$5.99B
| $90K | ﹤0.01% |
517
-11
| -2% | -$1.8K |
|
1412
TKO Group
TKO
$13.6B
| $90K | ﹤0.01% |
1,050
-177
| -14% | -$14.7K |
|
1413
Xerox
XRX
$424M
| $90K | ﹤0.01% |
5,044
-2,578
| -34% | -$45.3K |
|
1414
Archrock
AROC
$5.84B
| $89K | ﹤0.01% |
4,556
-344
| -7% | -$5.88K |
|
1415
Orion
OEC
$408M
| $89K | ﹤0.01% |
3,791
+3,534
| +1,375% | +$81.7K |
|
1416
SiriusXM
SIRI
$10B
| $89K | ﹤0.01% |
2,300
+739
| +47% | +$35.1K |
|
1417
Ameresco
AMRC
$1.38B
| $87K | ﹤0.01% |
3,639
| – | – |
|
1418
Cadeler
CDLR
$2.28B
| $87K | ﹤0.01% |
4,831
-364
| -7% | -$6.42K |
|
1419
Avita Medical
RCEL
$243M
| $87K | ﹤0.01% |
5,428
-388
| -7% | -$6.28K |
|
1420
Snap-on
SNA
$21.4B
| $87K | ﹤0.01% |
298
-1,732
| -85% | -$492K |
|
1421
Equity Residential
EQR
$25.1B
| $86K | ﹤0.01% |
1,377
| – | – |
|
1422
FirstService
FSV
$6.31B
| $86K | ﹤0.01% |
524
-240
| -31% | -$39.6K |
|
1423
International General Insurance
IGIC
$1.14B
| $86K | ﹤0.01% |
6,366
-128
| -2% | -$1.67K |
|
1424
Ligand Pharmaceuticals
LGND
$5.78B
| $86K | ﹤0.01% |
1,185
| – | – |
|
1425
Insmed
INSM
$28.6B
| $85K | ﹤0.01% |
3,136
-230
| -7% | -$6.44K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Lazard Asset Management held 2,474 positions worth $82.3B, up 4.1% from $79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $7.73B in Q1 2024, closing 424 positions and reducing 953 holdings. Its most notable exit was PPL Corp, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in GMO US Quality ETF worth $10.8M.
- Lazard Asset Management's largest Q1 2024 buy was GMO US Quality ETF: 362,290 shares worth $10.8M.
- Lazard Asset Management added most to Apple in Q1 2024, an estimated $983M increase.
- Lazard Asset Management's biggest Q1 2024 reduction was Alphabet (Google) Class A, cutting an estimated $795M.
- Lazard Asset Management fully exited PPL Corp in Q1 2024, selling an estimated $355M.
- Lazard Asset Management's ten largest holdings make up 24% of its $82.3B portfolio in Q1 2024.
- Lazard Asset Management opened 201 new positions and closed 424 in Q1 2024.
- Lazard Asset Management's portfolio value rose 4.1% quarter-over-quarter to $82.3B.
Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.